Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: Results of a multicenter, randomized, double-blind, placebo controlled, parallel group study

Journal of Urology

Volumn 190, Issue 3, 2013, Pages 958-964

  Sand, Peter K ^a   Dmochowski, Roger R ^b   Reddy, Jyotsna ^c   Van Der Meulen, Egbert A ^d  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Reproductive Health and Urology   (United States)

^d International PharmaScience Center   (Denmark)

Author keywords

deamino arginine vasopressin; nocturia; placebos; quality of life

Indexed keywords

DESMOPRESSIN; PLACEBO; SODIUM;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICATION ERROR; MULTICENTER STUDY; NOCTURIA; PARALLEL DESIGN; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; SLEEP QUALITY; SODIUM BLOOD LEVEL; SOMNOLENCE; TABLET DISINTEGRATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URINE VOLUME; XEROSTOMIA;

ADR; ADVERSE DRUG REACTION; ADVERSE EVENTS; AES; DEAMINO ARGININE VASOPRESSIN; MED; MINIMUM EFFECTIVE DOSE; N-QOL; NOCTURIA; NOCTURIA QUALITY OF LIFE; NOCTURNAL POLYURIA; NP; OAB; ODT; ORALLY DISINTEGRATING TABLET; OVERACTIVE BLADDER; PLACEBOS; QOL; QUALITY OF LIFE; WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT; WPAI;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIDIURETIC AGENTS; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOCTURIA; PATIENT SAFETY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881481634     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.02.037     Document Type: Article

References (30)

1. P. van Kerrebroeck, P. Abrams, D. Chaikin The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 179
2. B.T. Haylen, D. de Ridder, R.M. Freeman An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction Int Urogynecol J 21 2010 5
3. J.L. Bosch, J.P. Weiss The prevalence and causes of nocturia J Urol 184 2010 440
4. V. Kupelian, J.T. Wei, M.P. O'Leary Nocturia and quality of life: results from the Boston Area Community Health survey Eur Urol 61 2012 78
5. V. Kupelian, M.P. Fitzgerald, S.A. Kaplan Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey J Urol 185 2011 571
6. D.J. Lightner, A.E. Krambeck, D.J. Jacobson Nocturia is associated with an increased risk of coronary heart disease and death BJU Int 110 2012 848
7. H. Nakagawa, K. Niu, A. Hozawa Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study J Urol 184 2010 1413
8. S. Ancoli-Israel, D.L. Bliwise, J.P. Nørgaard The effect of nocturia on sleep Sleep Med Rev 15 2011 91
9. R.A. Appell, P.K. Sand Nocturia: etiology, diagnosis, and treatment Neurourol Urodyn 27 2008 34
10. J.P. Weiss, N.R. Zinner, B.M. Klein Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial Neurourol Urodyn 31 2012 441
11. A.L. Smith, A.J. Wein Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? BJU Int 107 2011 1550
12. J.P. Weiss, J.G. Blaivas, D.L. Bliwise The evaluation and treatment of nocturia: a consensus statement BJU Int 108 2011 6
13. J.P. Weiss, P.E. Van Kerrebroeck, B.M. Klein Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia J Urol 186 2011 1358
14. P. Van Kerrebroeck, H. Hashim, T. Holm-Larsen Thinking beyond the bladder: antidiuretic treatment of nocturia Int J Clin Pract 64 2010 807
15. J.P. Nørgaard, H. Hashim, L. Malmberg Antidiuresis therapy: mechanism of action and clinical implications Neurourol Urodyn 26 2007 1008
16. P. Van Kerrebroeck, M. Rezapour, A. Cortesse Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study Eur Urol 52 2007 221
17. G. Lose, O. Lalos, R.M. Freeman Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women Am J Obstet Gynecol 189 2003 1106
18. G. Lose, A. Mattiasson, S. Walter Clinical experiences with desmopressin for long-term treatment of nocturia J Urol 172 2004 1021
19. P. Abrams, K.E. Andersson, L. Birder Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence Neurourol Urodyn 29 2010 213
20. J.W. Thüroff, P. Abrams, K.E. Andersson EAU guidelines on urinary incontinence Eur Urol 59 2011 387
21. A. Rembratt, A. Riis, J.P. Nørgaard Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia Neurourol Urodyn 25 2006 105
22. K.V. Juul, B.M. Klein, R. Sandström Gender difference in antidiuretic response to desmopressin Am J Physiol Renal Physiol 300 2011 F1116
23. S. Lee, B. Malhotra, D. Creanga A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder BMC Med Res Methodol 9 2009 55
24. A. Mangera, C.R. Chapple, Z.S. Kopp The placebo effect in overactive bladder syndrome Nat Rev Urol 8 2011 495
25. J.H. van Leeuwen, R. Castro, M. Busse The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms Eur Urol 50 2006 440
26. J.C. Nickel Placebo therapy of benign prostatic hyperplasia: a 25-month study Canadian PROSPECT Study Group Br J Urol 81 1998 383
27. D.G. Finniss, T.J. Kaptchuk, F. Miller Biological, clinical, and ethical advances of placebo effects Lancet 375 2010 686
28. M.C. Reilly, A.S. Zbrozek, E.M. Dukes The validity and reproducibility of a work productivity and activity impairment instrument Pharmacoeconomics 4 1993 353
29. M. Prasad, P. Wahlqvist, R. Shikiar A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective Pharmacoeconomics 22 2004 225
30. G. Kobelt, F. Borgström, A. Mattiasson Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia BJU Int 91 2003 190